• Himax Technologies and WAFERLOCK Corporation recently announced that Himax’s WiseEye palm vein biometric authentication has been commercially integrated into WAFERLOCK’s newly launched L322 palm vein smart lock, which supports multiple access methods including palm recognition, RFID cards, PIN codes, mechanical keys, and an optional mobile app.
• This collaboration showcases how Himax’s on-device, ultralow power AI vision platform can enable secure, contactless biometric access for smart homes and buildings without relying on cloud connectivity, reinforcing the role of endpoint AI in privacy-focused access control.
• We’ll now examine how this commercialization of WiseEye palm vein authentication in a smart lock broadens Himax’s AI vision narrative and addressable markets.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Himax Technologies Investment Narrative Recap

To own Himax, you need to believe its shift from traditional display drivers toward higher value AI vision and sensing, like WiseEye, can offset margin pressure and demand volatility in core segments. The WAFERLOCK L322 integration is an encouraging proof point for WiseEye’s commercialization, but it is still too early to say it meaningfully changes the key near term catalyst of broader AI design wins or the biggest risk of uneven end market demand and rising costs.

Among recent news, Himax’s Q2 2026 results and Q3 guidance matter most here: modest year on year sales growth to US$227.37 million, improved quarterly net income, and an outlook for 7% to 11% sequential revenue growth frame how much room the company has to keep funding WiseEye and other AI initiatives while margins remain under pressure.

Yet against this promise of endpoint AI, investors should also recognize the risk that rising operating expenses and demand swings could...

Himax Technologies' narrative projects $1.8 billion revenue and $324.3 million earnings by 2029. This requires 29.3% yearly revenue growth and an earnings increase of about $289 million from $35.3 million today.

Uncover how Himax Technologies' forecasts yield a $30.20 fair value, a 115% upside to its current price.

Exploring Other Perspectives

While the WiseEye smart lock win fits the bullish view that low power AI can lift margins, the most optimistic analysts were already modeling revenue at about US$2.0 billion and earnings near US$352.9 million by 2029, so this news could either reinforce or challenge how confident you feel about that upside path.

Explore 6 other fair value estimates on Himax Technologies - why the stock might be worth over 3x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Himax Technologies research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Himax Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Himax Technologies' overall financial health at a glance.

Contemplating Other Strategies?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it. Find the list for free.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 38 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.